Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles

Prostate

Volumn 70, Issue 7, 2010, Pages 710-717

  Maxeiner, Andreas ^a,b   Adkins, Christen B ^a   Zhang, Yifen ^a   Taupitz, Matthias ^b   Halpern, Elkan F ^a   McDougal, W Scott ^a   Wu, Chin Lee ^a   Cheng, Leo L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

High resolution magic angle spinning; Magnetic resonance spectroscopy; Prostate cancer recurrence; Prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PRINCIPAL COMPONENT ANALYSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 77951826127     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21103     Document Type: Article

References (16)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Andriole GL, Crawford ED, Grubb RL III, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009;360(13):1310-1319.
3. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Maattanen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360(13):1320-1328.
4. Shariat SF, Karakiewicz PI, Suardi N, Kattan MW. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: A critical analysis of the literature. Clin Cancer Res 2008;14(14):4400-4407.
5. Shariat SF, Karakiewicz PI, Margulis V, Kattan MW. Inventory of prostate cancer predictive tools. Curr Opin Urol 2008;18(3):279-296. (Pubitemid 351489379)
6. Karakiewicz PI, Hutterer GC. Predictive models and prostate cancer. Nat Clin Pract Urol 2008;5(2):82-92.
7. Shariat SF, Walz J, Roehrborn CG, Zlotta AR, Perrotte P, Suardi N, Saad F, Karakiewicz PI. External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy. J Clin Oncol 2008;26(9):1526-1531.
8. Steuber T, O'Brien MF, Lilja H. Serum markers for prostate cancer: A rational approach to the literature. Eur Urol 2008;54(1):31-40.
9. Makarov DV, Trock BJ, Humphreys EB, Mangold LA, Walsh PC, Epstein JI, Partin AW. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology 2007;69(6):1095-1101.
10. Hara R, Jo Y, Fujii T, Kondo N, Yokoyoma T, Miyaji Y, Nagai A. Optimal approach for prostate cancer detection as initial biopsy: Prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Urology 2008;71(2):191-195. (Pubitemid 351282351)
11. Wright JL, Lange PH. Newer potential biomarkers in prostate cancer. Rev Urol 2007;9(4):207-213.
12. Lilja H, Ulmert D, Vickers AJ. Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring. Nat Rev Cancer 2008;8(4):268-278. (Pubitemid 351430866)
13. Cheng LL, Burns MA, Taylor JL, He W, Halpern EF, McDougal WS, Wu CL. Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Res 2005;65(8):3030-3034. (Pubitemid 40524579)
14. Taylor JL, Wu CL, Cory D, Gonzalez RG, Bielecki A, Cheng LL. High-resolution magic angle spinning proton NMR analysis of human prostate tissue with slow spinning rates. Magn Reson Med 2003;50(3):627-632. (Pubitemid 37082089)
15. Cheng LL, Pohl U. The role of NMR-based metabolomics in cancer. In: Lindon JC, Nicholls JK, Holmes E, editors. The handbook of metabonomics and metabolomics. Amsterdam: Elsevier; 2007. pp 345-374.
16. Scher HI, Leibel SA, Fuks Z, Cordon-Cardo C, Scardino PT. Cancer of the prostate. In: DeVita V, Hellman S, Rosenberg S, editors. Cancer: Principle and practice of oncology, 7th edition. Philadelphia: Lippincott Williams & Wilkins; 2005. pp 1192-1259.